KMT2A and mixed phenotype acute leukemia: Similarly, we derive a transcriptionally based prognostic metric, MPAL95, that validates in two independent cohorts of adult and pediatric patients with MPAL profiled by bulk RNA sequencing, including patients with ZNF384, BCL11B, and KMT2A rearrangements42,43.